Drug product

ABL Europe provides viral vector aseptic drug product manufacturing services in-house using a Bausch and Straubel filling machine located in a rigid isolator.

Automated liquid filling operations are aseptically validated using Pharmaceutical industry standard vials and stoppers, providing clients with the security of an integrity tested container / closure, with a long-term supply chain.

ABL offers the following filling and finishing operations:

  • DIN 2R and 2mL type 1 borosilicate glass vials
  • 13 mm chlorobutyl and bromobutyl stoppers and flip-off caps
  • < 10,000 vials per batch (filling speed 3,000 units per hour)
  • Phase 1 – 3 clinical supply, including engineering / toxicology supply runs
  • Process validation batches, supporting product licensure
  • Fully comprehensive in-house QC release & stability testing
  • Standalone viral vector aseptic filling finishing services are provided. Manual filling of smaller batches sizes can also be considered.